The Pathogenesis of Pituitary Tumors

被引:190
作者
Asa, Sylvia L. [1 ]
Ezzat, Shereen [2 ]
机构
[1] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON M5G 2M9, Canada
关键词
differentiation; proliferation; oncogenes; tumor suppressors; epigenetics; FIBROBLAST-GROWTH-FACTOR; HORMONE-RELEASING FACTOR; RECEPTOR-DEFICIENT MICE; MESSENGER-RIBONUCLEIC-ACID; ADENYLATE-CYCLASE ACTIVITY; HUMAN SOMATOTROPH TUMORS; RAT PROLACTIN GENE; GLUCOCORTICOID-RECEPTOR; ESTROGEN-RECEPTOR; THYROID-HORMONE;
D O I
10.1146/annurev.pathol.4.110807.092259
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recently there has been significant progress in our understanding of pituitary development, physiology, and pathology. New information has helped to clarify the classification of pituitary tumors. Epidemiologic analyses have identified a much higher incidence of pituitary tumors than previously thought. We review the pathogenetic factors that have been implicated in pituitary tumorigenesis and the application of novel targeted therapies that underscore the increasingly important role of the pathologist in determining accurate diagnoses and facilitating appropriate treatment of patients with these disorders.
引用
收藏
页码:97 / 126
页数:30
相关论文
共 151 条
[1]   Altered expression of fibroblast growth factor receptors in human pituitary adenomas [J].
Abbass, SAA ;
Asa, SL ;
Ezzat, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1160-1166
[2]   Divergent roles for thyroid hormone receptor β isoforms in the endocrine axis and auditory system [J].
Abel, ED ;
Boers, ME ;
Pazos-Moura, C ;
Moura, E ;
Kaulbach, H ;
Zakaria, M ;
Lowell, B ;
Radovick, S ;
Liberman, MC ;
Wondisford, F .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :291-300
[3]   CLINICALLY NONFUNCTIONING PITUITARY-TUMORS ARE MONOCLONAL IN ORIGIN [J].
ALEXANDER, JM ;
BILLER, BMK ;
BIKKAL, H ;
ZERVAS, NT ;
ARNOLD, A ;
KLIBANSKI, A .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :336-340
[4]   Invasive Pituitary Adenomas: Significance of Proliferation Parameters [J].
Amar A.P. ;
Hinton D.R. ;
Krieger M.D. ;
Weiss M.H. .
Pituitary, 1999, 2 (2) :117-122
[5]   Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance [J].
Ando, S ;
Sarlis, NJ ;
Krishnan, J ;
Feng, X ;
Refetoff, S ;
Zhang, MQ ;
Oldfield, EH ;
Yen, PM .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (09) :1529-1538
[6]  
Asa S L, 1984, Pathol Annu, V19 Pt 1, P275
[7]   CELL-TYPE-SPECIFIC EXPRESSION OF THE PITUITARY TRANSCRIPTION ACTIVATOR PIT-1 IN THE HUMAN PITUITARY AND PITUITARY-ADENOMAS [J].
ASA, SL ;
PUY, LA ;
LEW, AM ;
SUNDMARK, VC ;
ELSHOLTZ, HP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1275-1280
[8]  
ASA SL, 1982, ARCH PATHOL LAB MED, V106, P360
[9]   Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice [J].
Asa, SL ;
Coschigano, KT ;
Bellush, L ;
Kopchick, JJ ;
Ezzat, S .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :1009-1015
[10]   The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph [J].
Asa, SL ;
Bamberger, AM ;
Cao, B ;
Wong, M ;
Parker, KL ;
Ezzat, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2165-2170